aTyr Pharma, Inc. (NASDAQ:ATYR) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Mark Alan Goldberg Other companies: Blueprint Medicines Corp (Director · Since at least Jun 25, 2015); Audentes Therapeutics Inc (Director · Dec 11, 2017 – Jan 15, 2020 · Past); Crescent Biopharma, Inc. (Director · Jul 8, 2014 – May 1, 2024 · Past); Aceragen Inc. (Director · Jan 7, 2014 – Jun 23, 2022 · Past); ImmunoGen Inc (Director · Nov 8, 2011 – Feb 12, 2024 · Past); Synageva BioPharma Corp (EVP, Medical & Reg. Strategy · Nov 2, 2011 – Sep 19, 2014 · Past) | Director · May 6, 2015 – May 9, 2017 · Past |
| Jill Marie Broadfoot Other companies: Cue Biopharma, Inc. (Director · Since at least Jun 4, 2025); Talphera, Inc. (Director · Since at least Nov 20, 2021); Otonomy Inc (Director · Aug 18, 2021 – Jun 21, 2022 · Past); Vical Incorporated (Sr Vice President, CFO, Sec · Jan 7, 2011 – Apr 1, 2013 · Past) | Chief Financial Officer · Since at least Jul 30, 2018 |
| John Mendlein Other companies: Fate Therapeutics, Inc. (Director · Since at least Sep 30, 2013); Omega Therapeutics Inc (Director · Jul 29, 2021 – Jun 20, 2024 · Past); Moderna, Inc. (See Remarks · Dec 7, 2018 – Dec 7, 2018 · Past); Editas Medicine, Inc. (Director · Feb 2, 2016 – Jun 15, 2017 · Past) | Director · May 6, 2015 – May 8, 2019 · Past |
| Andrew Cubitt | VP, Product Protection · May 6, 2015 – Sep 13, 2016 · Past |
| Ashlee Dunston | Investor Relations and Public Affairs · Since at least Oct 29, 2026 |
| Brandon Yaras | Chief Financial Officer · Since at least Aug 10, 2026 |
| Danielle Campbell | VP, Human Resources · Since at least Nov 5, 2026 |
| Eric Benevich | Director · Since at least Dec 12, 2024 |
| Fred Ramsdell | VP, Immunology · May 6, 2015 – Oct 1, 2015 · Past |
| Jane A. Gross | Director · Since at least Nov 5, 2026 |
| Leslie Nangle | VP, Research · Since at least Oct 13, 2026 |
| Lisa Carey | VP, Clinical Operations · Since at least Sep 30, 2025 |
| Nancy Denyes | General Counsel · Since at least Jan 5, 2024 |
| Sanjay S. Shukla | President and CEO, Director · Since at least Mar 30, 2016 |
| Sara L. Zaknoen | Director · Since at least Nov 5, 2026 |
| Stan Blackburn | Acting Chief Financial Officer · May 6, 2015 – Jan 27, 2016 · Past |
| Svetlana Lucas | Director · Since at least Nov 5, 2026 |
| Timothy P. Coughlin | Chairman · Since at least Dec 12, 2024 |